1. Home
  2. TTC vs ABVX Comparison

TTC vs ABVX Comparison

Compare TTC & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toro Company (The)

TTC

Toro Company (The)

HOLD

Current Price

$89.82

Market Cap

9.3B

ML Signal

HOLD

Logo Abivax SA American

ABVX

Abivax SA American

HOLD

Current Price

$73.65

Market Cap

9.7B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTC
ABVX
Founded
1914
2013
Country
United States
France
Employees
N/A
67
Industry
Tools/Hardware
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
9.7B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
TTC
ABVX
Price
$89.82
$73.65
Analyst Decision
Buy
Buy
Analyst Count
4
13
Target Price
$104.00
$131.31
AVG Volume (30 Days)
658.4K
966.2K
Earning Date
06-04-2026
03-23-2026
Dividend Yield
1.66%
N/A
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
$2,618,650,000.00
N/A
Revenue This Year
$6.13
$52.14
Revenue Next Year
$4.45
$4,132.27
P/E Ratio
$130.41
N/A
Revenue Growth
4.53
N/A
52 Week Low
$67.45
$5.75
52 Week High
$105.19
$148.83

Technical Indicators

Market Signals
Indicator
TTC
ABVX
Relative Strength Index (RSI) 39.02 23.77
Support Level $86.95 $67.15
Resistance Level $97.32 $130.98
Average True Range (ATR) 2.50 6.25
MACD -0.00 -2.49
Stochastic Oscillator 34.62 6.25

Price Performance

Historical Comparison
TTC
ABVX

About TTC Toro Company (The)

The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: